1. Our scientific focus
  2. Product portfolio

Product portfolio

In the Europe, Middle East and Africa region we have a comprehensive portfolio across glaucoma and dry eye, and are currently expanding into the surgical and vision correction arenas, with our PRESERFLO™ MicroShunt* device and novel intraocular lens (IOL).

Glaucoma portfolio

Santen is a leading company in glaucoma care, with prescription medications to address every step of the disease. We are also expanding our portfolio with the PRESERFLO™ MicroShunt* surgical device.

Dry eye disease portfolio 

Santen has a growing portfolio of treatments for dry eye disease (DED or keratoconjunctivitis sicca) which occurs when there’s a problem with the tear film that normally keeps the eyes moist and lubricated, leading to inflammation and damage.

*PRESERFLO™ is the new trademark of Innfocus MicroShunt®. PRESERFLO™ MicroShunt will replace Innfocus MicroShunt® in the future.